Onconetix, Inc. (NASDAQ:ONCO) stock is moving higher Friday. Altos Venture filed a Form 13D with the Securities and Exchange Commission on Thursday, reporting a 32.5% stake in the company as of September 24.
What To Know: The 32.5% stake in Onconetix equates to 2,695,931 shares, which Altos acquired through multiple transactions.
The position includes shares obtained via a combination of stock conversion and a private placement, in which Altos also provided a $5 million debenture. The stock conversion turned Altos Venture's 800,358 shares of Series B Convertible Preferred Stock into common shares.
How To Buy Onconetix Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Onconetix (NASDAQ:ONCO)'s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Related Link: 'Safety Disaster:' Tesla FSD 'Galaxies Away From Being Anywhere Close To Competition,' Says Bearish Analyst, As He Assigns Zero Valuation To The Tech
ONCO Price Action: At the time of writing, Onconetix stock is trading 51.8% higher at $5.09, according to data from Benzinga Pro.
Image: Image via Pixabay